TY - JOUR AU - Deshayes, E. AU - Roumiguie, M. AU - Thibault, C. AU - Beuzeboc, P. AU - Cachin, F. AU - Hennequin, C. PY - 2017 DA - 2017// TI - Radium 223 dichloride for prostate cancer treatment JO - Drug Des Devel Ther VL - Volume 11 UR - https://doi.org/10.2147/DDDT.S122417 DO - 10.2147/DDDT.S122417 ID - Deshayes2017 ER - TY - STD TI - ClinicalTrials.gov n.d. https://clinicaltrials.gov/. Accessed 30 Sept 2018. UR - https://clinicaltrials.gov/ ID - ref2 ER - TY - STD TI - Flux GD. Imaging and dosimetry for radium-223: the potential for personalized treatment. Br J Radiol. 2017. https://doi.org/10.1259/bjr.20160748. ID - ref3 ER - TY - JOUR AU - Nilsson, S. AU - Franzén, L. AU - Parker, C. AU - Tyrrell, C. AU - Blom, R. AU - Tennvall, J. PY - 2007 DA - 2007// TI - Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study JO - Lancet Oncol VL - 8 UR - https://doi.org/10.1016/S1470-2045(07)70147-X DO - 10.1016/S1470-2045(07)70147-X ID - Nilsson2007 ER - TY - JOUR AU - Liepe, K. PY - 2009 DA - 2009// TI - Alpharadin, a 223Ra-based alpha-particle-emitting pharmaceutical for the treatment of bone metastases in patients with cancer JO - Curr Opin Investig Drugs VL - 10 ID - Liepe2009 ER - TY - JOUR AU - Nilsson, S. AU - Strang, P. AU - Aksnes, A. K. AU - Franzèn, L. AU - Olivier, P. AU - Pecking, A. PY - 2012 DA - 2012// TI - A randomized, dose–response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer JO - Eur J Cancer VL - 48 UR - https://doi.org/10.1016/j.ejca.2011.12.023 DO - 10.1016/j.ejca.2011.12.023 ID - Nilsson2012 ER - TY - JOUR AU - Nilsson, S. AU - Franzén, L. AU - Parker, C. AU - Tyrrell, C. AU - Blom, R. AU - Tennvall, J. PY - 2013 DA - 2013// TI - Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases JO - Clin Genitourin Cancer VL - 11 UR - https://doi.org/10.1016/j.clgc.2012.07.002 DO - 10.1016/j.clgc.2012.07.002 ID - Nilsson2013 ER - TY - JOUR AU - Parker, C. C. AU - Pascoe, S. AU - Chodacki, A. AU - O’Sullivan, J. M. AU - Germá, J. R. AU - O’Bryan-Tear, C. G. PY - 2013 DA - 2013// TI - A randomized, double-blind, dose-finding, multicenter, phase 2 study of radium chloride (Ra 223) in patients with bone metastases and castration-resistant prostate cancer JO - Eur Urol VL - 63 UR - https://doi.org/10.1016/j.eururo.2012.09.008 DO - 10.1016/j.eururo.2012.09.008 ID - Parker2013 ER - TY - JOUR AU - Parker, C. AU - Nilsson, S. AU - Heinrich, D. AU - Helle, S. I. AU - O’Sullivan, J. M. AU - Fosså, S. D. PY - 2013 DA - 2013// TI - Alpha emitter radium-223 and survival in metastatic prostate cancer JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1213755 DO - 10.1056/NEJMoa1213755 ID - Parker2013 ER - TY - JOUR AU - Humm, J. L. AU - Sartor, O. AU - Parker, C. AU - Bruland, O. S. AU - Macklis, R. PY - 2015 DA - 2015// TI - Radium-223 in the treatment of osteoblastic metastases: a critical clinical review JO - Int J Radiat Oncol Biol Phys VL - 91 UR - https://doi.org/10.1016/j.ijrobp.2014.12.061 DO - 10.1016/j.ijrobp.2014.12.061 ID - Humm2015 ER - TY - JOUR AU - Florimonte, L. AU - Dellavedova, L. AU - Maffioli, L. S. PY - 2016 DA - 2016// TI - Radium-223 dichloride in clinical practice: a review JO - Eur J Nucl Med Mol Imaging VL - 43 UR - https://doi.org/10.1007/s00259-016-3386-5 DO - 10.1007/s00259-016-3386-5 ID - Florimonte2016 ER - TY - STD TI - International Commission on Radiological Protection. Nuclear decay data for dosimetric calculations. ICRP Publication 107. Ann. ICRP 2008; 38(3).  ID - ref12 ER - TY - JOUR AU - Carrasquillo, J. A. AU - O’Donoghue, J. A. AU - Pandit-Taskar, N. AU - Humm, J. L. AU - Rathkopf, D. E. AU - Slovin, S. F. PY - 2013 DA - 2013// TI - Phase I pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cancer JO - Eur J Nucl Med Mol Imaging VL - 40 UR - https://doi.org/10.1007/s00259-013-2427-6 DO - 10.1007/s00259-013-2427-6 ID - Carrasquillo2013 ER - TY - JOUR AU - Pacilio, M. AU - Cassano, B. AU - Chiesa, C. AU - Giancola, S. AU - Ferrari, M. AU - Pettinato, C. PY - 2016 DA - 2016// TI - The Italian multicentre dosimetric study for lesion dosimetry in 223Ra therapy of bone metastases: calibration protocol of gamma cameras and patient eligibility criteria JO - Phys Medica Eur J Med Phys VL - 32 ID - Pacilio2016 ER - TY - JOUR AU - Hindorf, C. AU - Chittenden, S. J. AU - Aksnes, A. -. K. AU - Parker, C. AU - Flux, G. D. PY - 2012 DA - 2012// TI - Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastases JO - Nucl Med Commun VL - 33 UR - https://doi.org/10.1097/MNM.0b013e328353bb6e DO - 10.1097/MNM.0b013e328353bb6e ID - Hindorf2012 ER - TY - JOUR AU - Pacilio, M. AU - Ventroni, G. AU - Vincentis, G. AU - Cassano, B. AU - Pellegrini, R. AU - Castro, E. PY - 2016 DA - 2016// TI - Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223Ra-dichloride JO - Eur J Nucl Med Mol Imaging VL - 43 UR - https://doi.org/10.1007/s00259-015-3150-2 DO - 10.1007/s00259-015-3150-2 ID - Pacilio2016 ER - TY - JOUR AU - Yoshida, K. AU - Kaneta, T. AU - Takano, S. AU - Sugiura, M. AU - Kawano, T. AU - Hino, A. PY - 2016 DA - 2016// TI - Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases JO - Ann Nucl Med VL - 30 UR - https://doi.org/10.1007/s12149-016-1093-8 DO - 10.1007/s12149-016-1093-8 ID - Yoshida2016 ER - TY - JOUR AU - Mínguez, P. AU - Iturriaga, A. G. AU - Fernández, I. L. AU - Rodeño, E. PY - 2018 DA - 2018// TI - Detection and quantification of 223 Ra uptake in bone metastases of patients with castration-resistant prostate carcinoma, with the aim of determining the absorbed dose in the metastases JO - Rev Española Med Nucl e Imagen Mol (English Ed) VL - 37 ID - Mínguez2018 ER - TY - JOUR AU - Pacilio, M. AU - Ventroni, G. AU - Cassano, B. AU - Ialongo, P. AU - Lorenzon, L. AU - Castro, E. PY - 2016 DA - 2016// TI - A case report of image-based dosimetry of bone metastases with Alpharadin (223Ra-dichloride) therapy: inter-fraction variability of absorbed dose and follow-up JO - Ann Nucl Med VL - 30 UR - https://doi.org/10.1007/s12149-015-1044-9 DO - 10.1007/s12149-015-1044-9 ID - Pacilio2016 ER - TY - JOUR AU - Pacilio, M. AU - Cassano, B. AU - Pellegrini, R. AU - Castro, E. AU - Zorz, A. AU - Vincentis, G. PY - 2017 DA - 2017// TI - Gamma camera calibrations for the Italian multicentre study for lesion dosimetry in 223Ra therapy of bone metastases JO - Phys Medica Eur J Med Phys VL - 41 ID - Pacilio2017 ER - TY - JOUR AU - Flux, G. AU - Bardies, M. AU - Monsieurs, M. AU - Savolainen, S. AU - Strands, S. -. E. AU - Lassmann, M. PY - 2006 DA - 2006// TI - The impact of PET and SPECT on dosimetry for targeted radionuclide therapy JO - Z Med Phys VL - 16 UR - https://doi.org/10.1078/0939-3889-00291 DO - 10.1078/0939-3889-00291 ID - Flux2006 ER - TY - JOUR AU - Siegel, J. A. AU - Thomas, S. R. AU - Stubbs, J. B. AU - Stabin, M. G. AU - Hays, M. T. AU - Koral, K. F. PY - 1999 DA - 1999// TI - MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates JO - J Nucl Med Off Publ Soc Nucl Med VL - 40 ID - Siegel1999 ER - TY - JOUR AU - He, B. AU - Du, Y. AU - Segars, W. P. AU - Wahl, R. L. AU - Sgouros, G. AU - Jacene, H. PY - 2009 DA - 2009// TI - Evaluation of quantitative imaging methods for organ activity and residence time estimation using a population of phantoms having realistic variations in anatomy and uptake JO - Med Phys VL - 36 UR - https://doi.org/10.1118/1.3063156 DO - 10.1118/1.3063156 ID - He2009 ER - TY - JOUR AU - Owaki, Y. AU - Nakahara, T. AU - Kosaka, T. AU - Fukada, J. AU - Kumabe, A. AU - Ichimura, A. PY - 2017 DA - 2017// TI - Ra-223 SPECT for semi-quantitative analysis in comparison with Tc-99m HMDP SPECT: phantom study and initial clinical experience JO - EJNMMI Res VL - 7 UR - https://doi.org/10.1186/s13550-017-0330-z DO - 10.1186/s13550-017-0330-z ID - Owaki2017 ER - TY - JOUR AU - Jaszczak, R. J. AU - Floyd, C. E. AU - Coleman, R. E. PY - 1985 DA - 1985// TI - Scatter compensation techniques for spect JO - IEEE Trans Nucl Sci VL - 32 UR - https://doi.org/10.1109/TNS.1985.4336941 DO - 10.1109/TNS.1985.4336941 ID - Jaszczak1985 ER - TY - JOUR AU - Dewaraja, Y. K. AU - Frey, E. C. AU - Sgouros, G. AU - Brill, A. B. AU - Roberson, P. AU - Zanzonico, P. B. PY - 2012 DA - 2012// TI - MIRD pamphlet no. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy JO - J Nucl Med VL - 53 UR - https://doi.org/10.2967/jnumed.111.100123 DO - 10.2967/jnumed.111.100123 ID - Dewaraja2012 ER - TY - JOUR AU - D’Arienzo, M. AU - Cazzato, M. AU - Cozzella, M. L. AU - Cox, M. AU - D’Andrea, M. AU - Fazio, A. PY - 2016 DA - 2016// TI - Gamma camera calibration and validation for quantitative SPECT imaging with (177)Lu JO - Appl Radiat Isot Incl Data, Instrum Methods Use Agric Ind Med VL - 112 UR - https://doi.org/10.1016/j.apradiso.2016.03.007 DO - 10.1016/j.apradiso.2016.03.007 ID - D’Arienzo2016 ER - TY - BOOK AU - King, M. A. AU - Glick, S. J. AU - Pretorius, P. H. AU - Wells, R. G. AU - Gifford, H. C. AU - Narayanan, M. V. PY - 2004 DA - 2004// TI - Attenuation, scatter, and spatial resolution compensation in SPECT PB - Emiss Tomogr Acad Press CY - San Diego UR - https://doi.org/10.1016/B978-012744482-6.50025-9 DO - 10.1016/B978-012744482-6.50025-9 ID - King2004 ER - TY - JOUR AU - Royal, H. D. AU - Brown, P. H. AU - Claunch, B. C. PY - 1979 DA - 1979// TI - Effects of a reduction in crystal thickness on anger-camera performance JO - J Nucl Med VL - 20 ID - Royal1979 ER - TY - JOUR AU - Ritt, P. AU - Vija, H. AU - Hornegger, J. AU - Kuwert, T. PY - 2011 DA - 2011// TI - Absolute quantification in SPECT JO - Eur J Nucl Med Mol Imaging VL - 38 UR - https://doi.org/10.1007/s00259-011-1770-8 DO - 10.1007/s00259-011-1770-8 ID - Ritt2011 ER - TY - STD TI - Murray I, Chittenden SJ, Denis-Bacelar AM, Hindorf C, Parker CC, Chua S, et al. The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer. Eur J Nucl Med Mol Imaging. 2017. https://doi.org/10.1007/s00259-017-3744-y. ID - ref31 ER - TY - STD TI - Elaidi R, Vano YA, Aide N, Fournier L, Deandreis D, Tenenbaum F, et al. Phase I/II dose-finding, safety and efficacy study of radium-223 dichloride in renal cell carcinoma patients with bone metastases [abstract]. Ann Oncol. 2016;27(Suppl 6):853TiP. https://doi.org/10.1093/annonc/mdw373.80. ID - ref32 ER - TY - JOUR AU - Gerety, E. L. AU - Lawrence, E. M. AU - Wason, J. AU - Yan, H. AU - Hilborne, S. AU - Buscombe, J. PY - 2015 DA - 2015// TI - Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design JO - Ann Oncol Off J Eur Soc Med Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdv289. DO - 10.1093/annonc/mdv289. ID - Gerety2015 ER - TY - JOUR AU - Yue, J. AU - Frey, E. C. AU - Mauxion, T. AU - Josefsson, A. AU - Sgouros, G. AU - Hobbs, R. F. PY - 2015 DA - 2015// TI - Potential for quantitative imaging of Ra-223 JO - Int J Radiat Oncol Biol Phys VL - 93 UR - https://doi.org/10.1016/j.ijrobp.2015.07.1144 DO - 10.1016/j.ijrobp.2015.07.1144 ID - Yue2015 ER - TY - JOUR AU - Jan, S. AU - Santin, G. AU - Strul, D. AU - Staelens, S. AU - Assié, K. AU - Autret, D. PY - 2004 DA - 2004// TI - GATE: a simulation toolkit for PET and SPECT. - PubMed - NCBI JO - Phys Med Biol VL - 49 UR - https://doi.org/10.1088/0031-9155/49/19/007 DO - 10.1088/0031-9155/49/19/007 ID - Jan2004 ER - TY - JOUR AU - Letellier, A. AU - Johnson, A. C. AU - Kit, N. H. AU - Savigny, J. -. F. AU - Batalla, A. AU - Parienti, J. -. J. PY - 2018 DA - 2018// TI - Uptake of radium-223 dichloride and early [18 F] NaF PET response are driven by baseline [18 F] NaF parameters: a pilot study in castration-resistant prostate cancer patients JO - Mol Imaging Biol VL - 20 UR - https://doi.org/10.1007/s11307-017-1132-4 DO - 10.1007/s11307-017-1132-4 ID - Letellier2018 ER -